Pegcetacoplan compared with supportive care for 26 weeks for participants with paroxysmal nocturnal hemoglobinuria: a plain language summary
In the PRINCE study, adults with paroxysmal nocturnal hemoglobinuria (PNH) who had not recently taken a C5 complement inhibitor medicine received pegcetacoplan or supportive care. Pegcetacoplan reduced hemolysis better than supportive care and was well tolerated.
Gespeichert in:
| Veröffentlicht in: | Future Rare Diseases Jg. 4; H. 1 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Future Medicine Ltd
31.12.2024
|
| Schlagworte: | |
| ISSN: | 2399-5262, 2399-5270, 2399-5270 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | In the PRINCE study, adults with paroxysmal nocturnal hemoglobinuria (PNH) who had not recently taken a C5 complement inhibitor medicine received pegcetacoplan or supportive care. Pegcetacoplan reduced hemolysis better than supportive care and was well tolerated. |
|---|---|
| ISSN: | 2399-5262 2399-5270 2399-5270 |
| DOI: | 10.2217/frd-2023-0006 |